New combo therapy aims to reverse liver damage in diabetics
NCT ID NCT07303803
First seen Jan 07, 2026 · Last updated Jun 15, 2026 · Updated 21 times
Summary
This study tests whether adding chiglitazar to standard anti-inflammatory and liver-protecting treatments can help people with both fatty liver disease (MASH) and type 2 diabetes. About 300 adults will receive either the combination or a placebo, and doctors will check if liver inflammation resolves without worsening scarring. The goal is to control the disease and prevent progression, not to cure it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for T2DM (TYPE 2 DIABETES MELLITUS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ditan Hospital of integrated traditional Chinese and Western Medicine Center
NOT_YET_RECRUITINGBeijing, Beijing Municipality, 100015, China
-
Renji hospital of Shanghai Jiao Tong University School of Medical
NOT_YET_RECRUITINGShanghai, Shanghai Municipality, 200001, China
-
Ruijin Hospital of Shanghai Jiaotong University School of Medicine
NOT_YET_RECRUITINGShanghai, Shanghai Municipality, 200020, China
-
Shanghai Public Health Clinical Center
NOT_YET_RECRUITINGShanghai, Shanghai Municipality, 200083, China
-
Shanghai Punan Hospital of Pudong New District (Punan Branch of Renji Hospital, Shanghai Jiaotong University School of Medicine)
RECRUITINGShanghai, Shanghai Municipality, 200125, China
-
Southern Hospital
NOT_YET_RECRUITINGGuangzhou, Guangdong, 510515, China
-
Southwest Hospital of Third Military Medical University
NOT_YET_RECRUITINGChongqing, Chongqing Municipality, 400038, China
-
Taihe Hospital
NOT_YET_RECRUITINGShiyan, Hubei, 442000, China
-
The First Affiliated Hospital of Fujian Medical University
NOT_YET_RECRUITINGFuzhou, Fujian, 350005, China
-
The First Affiliated Hospital of Jilin University
NOT_YET_RECRUITINGChangchun, Jilin, 130021, China
-
The First Affiliated Hospital of Xi'an Jiao Tong University
NOT_YET_RECRUITINGXi’an, Shanxi, 710061, China
-
The First Affiliated Hospital of Zhejiang University
NOT_YET_RECRUITINGHangzhou, Zhejiang, 310003, China
-
The First Teaching Hospital of Xinjiang Medical University
NOT_YET_RECRUITINGÜrümqi, Xinjiang, 830054, China
-
The Third Affiliated Hospital of Sun Yat-sen University
NOT_YET_RECRUITINGGuangzhou, Guangdong, 510000, China
-
Tianjin Second People's Hospital
NOT_YET_RECRUITINGTianjin, Tianjin Municipality, 300192, China
-
Wuhan Union Hospital of Huazhong University of Science and Technology
NOT_YET_RECRUITINGWuhan, Hebei, 430022, China
-
Xiangya hospital of Central South University
NOT_YET_RECRUITINGChangsha, Hunan, 410008, China
Conditions
Explore the condition pages connected to this study.